None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Histologically confirmed colon adenocarcinoma of colon 2) No accompanying cancer 3) No distant metastasis 4) When surgical resection is performed 5) A person who has signed an agreement 6) Adults over the age of 20
Exclusion criteria
Exclusion criteria: 1) Accompanying cancer 2) Distant metastasis 3) No pre or postoperative imaging 4) A pregnant woman or a lactating woman 5) Currently or recently (within 28 randomized days) receiving another clinical trial medication or participating in another clinical trial 6) Mignant tumors in other tissues within the last 5 years 7) In the case of familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative hospitalization period: day of surgery - discharge date, postoperative complications: Infectious - wound complications, intra-abdominal inflammation, urinary tract infection, pneumonia, clostridium difficile infection/non-infectious - intestinal obstruction, bleeding, deep vein thrombosis | — |
Secondary
| Measure | Time frame |
|---|---|
| - Immune factor absolute value difference: IL-6, TNF-a, NK cell (difference between groups) - Differences in immune factor changes: IL-6, TNF-a, and NK cell changes by measurement period (difference between groups) - Differences in immune factors between myosteatosis and myopathy: Comparison of IL-6, TNF-a, NK cell absolute values and degree of change between myosteatosis and myopathy - Survival rate and recurrence rate in the elderly group: Comparison of survival rate and recurrence rate at the time of one or three years after surgery (by presence of immune factor,myosteatosis, and myopathy in the elderly group) | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center